Dietary Supplements for Pain Relief in Patients with Fibromyalgia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Am J Chin Med. 2022;50(5):1197-1218. doi: 10.1142/S0192415X22500495. Epub 2022 May 31.

Abstract

Pain is the most frequently encountered symptom by patients with fibromyalgia (FM). Dietary supplements (DSs) in particular have a proven impact as a possible adjunctive therapy for symptom management in FM. However, there is currently no conclusive review outlining the evidence for DSs in pain management in FM. This study aims to assess currently available studies evaluating the use of DSs for pain relief in FM. Randomized controlled trials regarding the use of DSs on adult FM patients were included for evidence synthesis. Study results indicated that DSs significantly relieved pain in FM (SMD 1.23; 95% CI 0.02-2.43, P = 0.046) but did not improve quality of life (QoL) (SMD 0.73; 95% CI -0.07-1.53, P = 0.075) in the data. Adverse events of DSs varied from mild to severe, with the most common being gastrointestinal symptoms and androgenic side effects in 5.7% and 3.9% of patients, respectively. More well-designed RCTs are required in the future. The protocol for this review has been published on PROSPERO (CRD42020149941).

Keywords: Clinical Trials; Dietary Supplements; Fibromyalgia; Herbal Medicine; Meta-Analysis; Pain Relief; Review.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Adult
  • Dietary Supplements
  • Fibromyalgia* / drug therapy
  • Humans
  • Pain / drug therapy
  • Pain / etiology
  • Pain Management / methods
  • Quality of Life
  • Randomized Controlled Trials as Topic